Roberts Christine L, Ford Jane B, Algert Charles S, Bell Jane C, Simpson Judy M, Morris Jonathan M
Clinical and Population Perinatal Health Research, The Kolling Institute of Medical Research, University of Sydney 2006, NSW, Australia.
BMC Pregnancy Childbirth. 2009 Feb 25;9:7. doi: 10.1186/1471-2393-9-7.
Maternal mortality is too rare in high income countries to be used as a marker of the quality of maternity care. Consequently severe maternal morbidity has been suggested as a better indicator. Using the maternal morbidity outcome indicator (MMOI) developed and validated for use in routinely collected population health data, we aimed to determine trends in severe adverse maternal outcomes during the birth admission and in particular to examine the contribution of postpartum haemorrhage (PPH).
We applied the MMOI to the linked birth-hospital discharge records for all women who gave birth in New South Wales, Australia from 1999 to 2004 and determined rates of severe adverse maternal outcomes. We used frequency distributions and contingency table analyses to examine the association between adverse outcomes and maternal, pregnancy and birth characteristics, among all women and among only those with PPH. Using logistic regression, we modelled the effects of these characteristics on adverse maternal outcomes. The impact of adverse outcomes on duration of hospital admission was also examined.
Of 500,603 women with linked birth and hospital records, 6242 (12.5 per 1,000) suffered an adverse outcome, including 22 who died. The rate of adverse maternal outcomes increased from 11.5 in 1999 to 13.8 per 1000 deliveries in 2004, an annual increase of 3.8% (95%CI 2.3-5.3%). This increase occurred almost entirely among women with a PPH. Changes in pregnancy and birth factors during the study period did not account for increases in adverse outcomes either overall, or among the subgroup of women with PPH. Among women with severe adverse outcomes there was a 12% decrease in hospital days over the study period, whereas women with no severe adverse outcome occupied 23% fewer hospital days in 2004 than in 1999.
Severe adverse maternal outcomes associated with childbirth have increased in Australia and the increase was entirely among women who experienced a PPH. Reducing or stabilising PPH rates would halt the increase in adverse maternal outcomes.
在高收入国家,孕产妇死亡极为罕见,无法作为衡量孕产妇保健质量的指标。因此,严重孕产妇发病被认为是一个更好的指标。我们使用为常规收集的人群健康数据开发并验证的孕产妇发病结局指标(MMOI),旨在确定分娩住院期间严重不良孕产妇结局的趋势,特别是研究产后出血(PPH)的影响。
我们将MMOI应用于1999年至2004年在澳大利亚新南威尔士州分娩的所有妇女的出生与医院出院记录链接数据,并确定严重不良孕产妇结局的发生率。我们使用频率分布和列联表分析来研究所有妇女以及仅产后出血妇女中不良结局与孕产妇、妊娠和分娩特征之间的关联。使用逻辑回归,我们对这些特征对不良孕产妇结局的影响进行建模。还研究了不良结局对住院时间的影响。
在500,603例有出生与医院记录链接的妇女中,6242例(每1000例中有12.5例)出现不良结局,其中22例死亡。不良孕产妇结局的发生率从1999年的每1000例分娩中有11.5例增加到2004年的每1000例中有13.8例,年增长率为3.8%(95%CI 2.3 - 5.3%)。这种增加几乎完全发生在产后出血的妇女中。研究期间妊娠和分娩因素的变化并不能解释总体不良结局的增加,也不能解释产后出血妇女亚组中不良结局的增加。在有严重不良结局的妇女中,研究期间住院天数减少了12%,而无严重不良结局的妇女在2004年的住院天数比1999年减少了23%。
在澳大利亚,与分娩相关的严重不良孕产妇结局有所增加,且增加完全发生在经历产后出血的妇女中。降低或稳定产后出血率将阻止不良孕产妇结局的增加。